Paediatrics

Atrx loss as a promising screening tool for the identification of diffuse midline glioma subtype, H3K27/MAPKinase co-altered

June 27, 2024 June 27, 2024

Acta Neuropathol Commun. 2024 Jun 27;12(1):105. doi: 10.1186/s40478-024-01818-8.

NO ABSTRACT

PMID:38926805 | DOI:10.1186/s40478-024-01818-8

John Joseph

JohnJAcademy.com

View all posts by John Joseph